Citations

Showing 10 of 108094 citations.

Re: Robotic versus Open Level I-II Inferior Vena Cava Thrombectomy: A Matched Group Comparative Analysis
Bhindi, Bimal , Leibovich, Bradley C.

Mayo Clinic

Journal of Urology | February 9, 2018 | Volume: 199 | Issue: 5 | Pages: 1351-1352

10.1016/j.juro.2017.12.044 | PMID 29428635 Get It

Contained right atrial rupture: an unusual presentation of a rare primary cardiac tumour
Lane, Colleen E. , Soto, Juan C. Diaz , Padang, Ratnasari , Diaz Soto, Juan C, Luis, Sushil A, Luis, Sushil Allen

Mayo Clinic

European Heart Journal | February 8, 2018 | Volume: 39 | Issue: 17 | Pages: 1574-1575

10.1093/eurheartj/ehy093 | PMID 29529184 Get It

The prognostic impact of periprocedural myocardial infarction and injury
Thygesen, Kristian , Jaffe, Allan S. , Jaffe, Allan S.

Mayo Clinic

European Heart Journal | February 8, 2018 | Volume: 39 | Issue: 13 | Pages: 1110-1112

10.1093/eurheartj/ehy089 | PMID 29529182 Get It

Serum vitamin C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein
Aumailley, Lucie , Dubois, Marie Julie, Brennan, Tracy A., Garand, Chantal , Paquet, Éric R. , Pignolo, Robert J. , Marette, André , Lebel, Michel

Mayo Clinic

The FASEB Journal | February 8, 2018 | Volume: 32 | Issue: 7 | Pages: 3623-3640

10.1096/fj.201701176r | PMID 29452565 Get It

Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ‐family DNA helicase (WRN). Mice lacking part of the helicase domain of the WRN ortholog exhibit several phenotypic features of WS. In this study, we generated a Wrn mutant line that, like humans, relies entirely on dietary sources of vitamin C (ascorbate) to survive, by crossing them to mice that lack the gulonolactone oxidase enzyme required for ascorbate synthesis. In the presence of 0.01% ascorbate (w/v) in drinking water, double‐mutant mice exhibited a severe reduction in lifespan, small size, sterility, osteopenia, and metabolic profiles different from wild‐type (WT) mice. Although increasing the dose of ascorbate to 0.4% improved dramatically the phenotypes of double‐mutant mice, the metabolic and cytokine profiles were different from age‐matched WT mice. Finally, double‐mutant mice treated with 0.01% ascorbate revealed a permanent activation of all the 3 branches of the ER stress response pathways due to a severe chronic oxidative stress in the ER compartment. In addition, markers associated with the ubiquitinproteasome‐dependent ER‐associated degradation pathway were increased. Augmenting the dose of ascorbate reversed the activation of this pathway to WT levels rendering this pathway a potential therapeutic target in WS.—Aumailley, L., Dubois, M. J., Brennan, T. A., Garand, C., Paquet, E. R., Pignolo, R. J., Marette, A., Lebel, M. Serum vitamin C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein. FASEB J. 32, 3623–3640 (2018). www.fasebj.org
Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis
Samadder, N. Jewel , Kuwada, Scott K., Byrne, Kathryn R., Samowitz, Wade S., Jones, David A. , Tavtigian, Sean V. , Westover, Michelle, Berry, Therese, Jasperson, Kory , Pappas, Lisa M. , Smith, Laurel, Sample, Danielle, Burt, Randall W., Neklason, Deborah W. , Boucher, Kenneth , Kanth, Priyanka

Mayo Clinic

JAMA Oncology | February 8, 2018 | Volume: 4 | Issue: 5 | Pages: 671

10.1001/jamaoncol.2017.5431 | PMID 29423501 Get It

Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin
Czeczok, Thomas , Stashek, Kristen , O’Dorisio, Thomas M. , Howe, James R. , Bellizzi, Andrew M. , Czeczok, Thomas W, Bellizzi, Andrew M , Maxwell, Jessica E. , Hornick, Jason L. , Howe, James R

Mayo Clinic

Applied Immunohistochemistry & Molecular Morphology | February 8, 2018 | Volume: 26 | Issue: 2 | Pages: 94-100

10.1097/pai.0000000000000563 | PMID 29420353 Get It

Clusterin, a widely expressed, tissue-specific glycoprotein, is a diagnostic marker of several tumor types, including anaplastic large cell lymphoma, follicular dendritic cell sarcoma, and tenosynovial giant cell tumor. A recent study has suggested it is highly expressed by well-differentiated neuroendocrine tumors (NET) arising at most anatomic sites, with the exception of jejunoileal tumors, and that it is similarly not expressed by poorly differentiated neuroendocrine carcinomas (NEC). We sought to validate this result in a large cohort of NETs and NECs. Clusterin immunohistochemistry was performed on tissue microarrays of 255 NETs [45 lung, 4 stomach, 8 duodenum, 75 pancreas (62 primary, 13 metastatic), 107 jejunoileum (69 primary, 38 metastatic), 16 appendix] and 88 NECs (43 visceral, 45 Merkel cell). Extent (%) and intensity (0, 1+, 2+, 3+) of staining were assessed and an H-score (extent x intensity) calculated. An average H-score >5 was considered positive. Clusterin expression was noted in 82.4% of 148 nonjejunoileal NETs (average H-score 183) and only 8.4% of 107 jejunoileal NETs (average H-score, 31), as well as 19.3% of NECs (average H-score, 36). Clusterin is frequently, strongly expressed by NETs of diverse anatomic sites, with the exception of jejunoileal tumors, in which it is only rarely, weakly expressed. It is occasionally, weakly expressed by NECs. Most metastatic NETs of occult origin arise in the pancreas or the jejunoileum. For cases in which an initial site of origin immunopanel (eg, islet 1, PAX6, CDX2) is ambiguous, addition of clusterin may be diagnostically useful, with absence of expression suggesting a jejunoileal origin.
Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
Liesman, Rachael M. , Strasburg, Angela P., Heitman, Angela K., Theel, Elitza S. , Patel, Robin , Binnicker, Matthew J. , Patel, Robin

Mayo Clinic

Journal of Clinical Microbiology | February 8, 2018 | Volume: 56 | Issue: 4 | Pages: No page available

10.1128/jcm.01927-17 | PMID 29436421 Get It

ABSTRACT Rapid and accurate laboratory tests are important for the timely diagnosis and treatment of central nervous system infections. The FilmArray meningitis/encephalitis (ME) panel (BioFire Diagnostics, Salt Lake City, UT) is an FDA-cleared, multiplex molecular panel that allows the detection of 14 pathogens (bacterial [ n = 6], viral [ n = 7], and fungal [ n = 1] pathogens) from cerebrospinal fluid (CSF). In this study, we evaluated the performance characteristics of the FilmArray ME panel using clinical, residual CSF samples ( n = 291) that tested positive by a routine method(s) (e.g., bacterial culture, individual real-time PCR assay) for a pathogen represented on the ME panel. Of note, a subset ( n = 76) of the CSF specimens was collected during the prevaccine era and had been characterized as positive for a bacterial pathogen. The FilmArray ME panel demonstrated an overall percent positive agreement (PPA) of 97.5% (78/80) for bacterial pathogens, 90.1% (145/161) for viruses, and 52% (26/50) for Cryptococcus neoformans/C. gattii . Despite the low overall agreement (52%) between the ME panel and antigen testing for detection of C. neoformans/C. gattii , the percent positive agreement of the FilmArray assay for C. neoformans/C. gattii was 92.3% (12/13) when the results were compared directly to the results of routine fungal smear or culture. The FilmArray ME panel offers a rapid (∼60-min), syndrome-based approach for the detection of select meningitis and encephalitis pathogens.
A Mixed-Methods Study on the Barriers and Facilitators of Telemedicine for Newborn Resuscitation
Fang, Jennifer L. , Asiedu, Gladys B. , Harris, Ann , Carroll, Katherine , Colby, Christopher E. , Harris, Ann M.

Mayo Clinic

Telemedicine and e-Health | February 8, 2018 | Volume: 24 | Issue: 10 | Pages: 811-817

10.1089/tmj.2017.0182 | PMID 29420138 Get It

Background: Teleneonatology may improve the quality of high-risk newborn resuscitations performed by general providers in community settings. Variables that affect teleneonatology utilization have not been identified. Introduction: The objective of our mixed-methods study was to understand the barriers and facilitators experienced by local care providers who receive teleneonatology services. Materials and Methods: In October 2015, an electronic survey was sent to 349 teleneonatology participants at 6 community hospitals to assess user satisfaction, technology usability and acceptability, and impact on patient care. From December 2015 to June 2016, 49 participants were involved in focus groups and individual interviews to better understand barriers and facilitators of teleneonatology implementation. Qualitative data were analyzed using a thematic approach. Results: Survey response rate was 31.8% ( N = 111). Of 93 survey respondents, 88 (94.6%) agreed that teleneonatology was needed at their hospitals, and of 52 participants, 50 (96.2%) believed that teleneonatology consults were helpful. We identified multiple facilitators and barriers to program implementation in education and training, process and work flow, communication, and technology. Discussion: Local care teams believed that teleneonatology was valuable for connection to a remote neonatologist. Successful program implementation may be facilitated by communicating the value of teleneonatology, engaging local stakeholders in program training and education, maintaining supportive professional relationships, and designing simple, highly reliable clinical work flows. Conclusions: Teleneonatology is viewed as an innovative, valuable service by local care teams. The identified barriers and facilitators to program use should be considered when implementing a teleneonatology program.
A simple and effective method to optimize limb position after complex lower limb free flap reconstruction with concurrent external fixation
Ciudad, Pedro , Vijayan, Roshan , Pafitanis, Georgios , Kaya, Burak , Pont, Luis Parra , Agko, Mouchammed , Manrique, Oscar J. , Kiranantawat, Kidakorn , Chang, Wei‐Ling , Parra Pont, Luis , Mouchammed, Agko , Chen, Hung‐Chi

Mayo Clinic

Microsurgery | February 8, 2018 | Volume: 39 | Issue: 1 | Pages: 98-99

10.1002/micr.30301 | PMID 29418025 Get It

Societal Identification of Facial Paralysis and Paralysis Location
Su, Peiyi , Ishii, Lisa E. , Nellis, Jason C. , Dey, Jacob K. , Bater, Kristin L., Byrne, Patrick J., Boahene, Kofi , Ishii, Masaru , Dey, Jacob, Dey, Jacob K

Mayo Clinic

JAMA Facial Plastic Surgery | February 8, 2018 | Volume: 20 | Issue: 4 | Pages: 272-276

10.1001/jamafacial.2017.2402 | PMID 29423522 Get It